Volume 24 Issue 2
Feb.  2026
Turn off MathJax
Article Contents
ZHAI Tianqi, JIANG Zhenyu, ZHANG Jingjie, NIAN Yuanyuan, MENG Xianmei. A two-sample Mendelian randomization study on the causal relationship between gastroesophageal reflux disease and irritable bowel syndrome[J]. Chinese Journal of General Practice, 2026, 24(2): 235-238. doi: 10.16766/j.cnki.issn.1674-4152.004368
Citation: ZHAI Tianqi, JIANG Zhenyu, ZHANG Jingjie, NIAN Yuanyuan, MENG Xianmei. A two-sample Mendelian randomization study on the causal relationship between gastroesophageal reflux disease and irritable bowel syndrome[J]. Chinese Journal of General Practice, 2026, 24(2): 235-238. doi: 10.16766/j.cnki.issn.1674-4152.004368

A two-sample Mendelian randomization study on the causal relationship between gastroesophageal reflux disease and irritable bowel syndrome

doi: 10.16766/j.cnki.issn.1674-4152.004368
Funds:

 2024ZD28

  • Received Date: 2025-09-11
    Available Online: 2026-04-11
  •   Objective  Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) are the most common gastrointestinal diseases. GERD and IBS have different degrees of impact on patients ' daily life, work and psychological state. This study aims to explore the causal relationship between GERD and IBS using Mendelian randomization (MR).  Methods  GERD data and IBS data were all from the GWAS database, including 1 590 227 GERD samples (462 753 cases in the case group and 1 127 474 cases in the control group) and 486 601 cases of IBS samples (53 400 cases in the case group and 433 201 cases in the control group). The above samples were all from the European population. IVW was used as the main analysis method to test the causal relationship between GERD and IBS. IVW and MR-Egger methods were used to test heterogeneity, MR-Egger regression intercept was used to test pleiotropy, "leave one" method was used to test the sensitivity of the study, and F value was used to test whether there was weak instrumental variable bias.  Results  When GERD was selected as exposure and IBS was used as the outcome, 191 cases of SNPs were screened and included. Results indicated that GERD was a risk factor for the occurrence of IBS, and there was a certain causal relationship (IVW method: OR=1.328, 95% CI: 1.269-1.390, P < 0.05). Reverse MR analysis showed that IBS also increased the risk of GERD (IVW method: OR=1.453, 95% CI: 1.092-1.932, P < 0.05).  Conclusion  There is a bidirectional causal relationship between GERD and IBS. The GERD increases the risk of IBS, and IBS also has a positive effect on GERD.

     

  • loading
  • [1]
    杜玄凌, 徐琦坪, 潘独伊, 等. 铝碳酸镁治疗反流性食管炎的Meta分析[J]. 中国循证医学杂志, 2018, 18(9): 924-930.

    DU X L, XU Q P, PAN D Y, et al. Meta-analysis of magnesium aluminum carbonate in the treatment of reflux esophagitis[J]. Chinese Journal of Evidence-Based Medicine, 2018, 18(9): 924-930.
    [2]
    RICHTER J E, RUBENSTEIN J H. Presentation and epidemiology of gastroesophageal reflux disease[J]. Gastroenterology, 2018, 154(2): 267-276. doi: 10.1053/j.gastro.2017.07.045
    [3]
    MARET-OUDA J, MARKAR S R, LAGERGREN J. Gastroesophageal reflux disease: a review[J]. Jama, 2020, 324(24): 2536-2547. doi: 10.1001/jama.2020.21360
    [4]
    YUAN S, LARSSON S C. Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study[J]. Eur J Epidemiol, 2022, 37(7): 747-754. doi: 10.1007/s10654-022-00842-z
    [5]
    何美君, 李晶, 孟子惠, 等. 从"肝-脑相关"探讨中枢敏化对非糜烂性胃食管反流病的影响及机制[J]. 中华中医药学刊, 2022, 40(3): 163-166.

    HE M J, LI J, MENG Z H, et al. The effect and mechanism of central sensitization on non-erosive gastroesophageal reflux disease from "liver-brain correlation"[J]. Chinese Journal of Traditional Chinese Medicine, 2022, 40(3): 163-166.
    [6]
    MEHTA R S, NGUYEN L H, MA W, et al. Association of diet and lifestyle with the risk of gastroesophageal reflux disease symptoms in US women[J]. JAMA Internal Med, 2021, 181(4): 552-554. doi: 10.1001/jamainternmed.2020.7238
    [7]
    CHENG Y, KOU F, LIU J, et al. Systematic assessment of environmental factors for gastroesophageal reflux disease: an umbrella review of systematic reviews and meta-analyses[J]. Dig Liver Dis, 2021, 53(5): 566-573. doi: 10.1016/j.dld.2020.11.022
    [8]
    HUANG K Y, WANG F Y, LYU M, et al. Irritable bowel syndrome: epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol, 2023, 29(26): 4120-4135. doi: 10.3748/wjg.v29.i26.4120
    [9]
    CAMILLERI M. Irritable Bowel Syndrome: straightening the road from the Rome criteria[J]. Neurogastroenterol Motil, 2020, 32(11): e13957. DOI: 10.1111/nmo.13957.
    [10]
    胡祥鹏, 张深深, 王乔, 等. 胃食管反流病重叠消化不良的临床及精神心理特征研究[J]. 中华全科医学, 2019, 17(9): 1447-1449, 1550. doi: 10.16766/j.cnki.issn.1674-4152.000966

    HU X P, ZHANG S S, WANG Q, et al. Clinical and psychosocial characteristics of overlapping indigestion in gastroesophageal reflux disease[J]. Zhonghua General Medicine, 2019, 17(9): 1447-1449, 1550. doi: 10.16766/j.cnki.issn.1674-4152.000966
    [11]
    HU Z, LI M, YAO L, et al. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis[J]. BMC Gastroenterology, 2021, 21(1): 23. DOI: 10.1186/s12876-020-01593-5.
    [12]
    BLACK C J, FORD A C. Global burden of irritable bowel syndrome: trends, predictions and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(8): 473-486. doi: 10.1038/s41575-020-0286-8
    [13]
    ALQAHTANI N H, MAHFOUZ M E M. The prevalence and risk factors of irritable bowel syndrome in Saudi Arabia in 2019[J]. Int J Prev Med, 2022, 13: 13. DOI: 10.4103/ijpvm.IJPVM_486_20.
    [14]
    JIN Y J, WU X Y, AN Z Y. The application of Mendelian randomization in cardiovascular disease risk prediction: current status and future prospects[J]. Rev Cardiovasc Med, 2024, 25(7): 262. DOI: 10.31083/j.rcm2507262.
    [15]
    DAVIES N M, HOLMES M V, DAVEY SMITH G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians[J]. BMJ, 2018, 362: k601. DOI: 10.1136/bmj.k601.
    [16]
    GHOLAMNEZHAD F, QEISARI A, SHAHRIARIRAD R. Gastroesophageal reflux disease incidence among male patients with irritable bowel syndrome: a single-center cross-sectional study in southern Iran[J]. JGH Open, 2023, 7(2): 152-156. doi: 10.1002/jgh3.12867
    [17]
    孙中美, 唐艳萍, 杨磊, 等. 便秘型和腹泻型肠易激综合征及其不同中医证型患者心理障碍情况分析[J/OL]. 辽宁中医杂志, 2025: 1-16. (2025-02-05)[2025-09-22]. https://link.cnki.net/urlid/21.1128.R.20250205.1536.025.

    SUN Z M, TANG Y P, YANG L, et al. Analysis of psychological disordersin patients with constipation-type and diarrheal irritable bowel syndrome and their different TCM syndromes[J/OL]. Liaoning Journal of Traditional Chinese Medicine, 2025: 1-16. (2025-02-05)[2025-09-22]. https://link.cnki.net/urlid/21.1128.R.20250205.1536.025.
    [18]
    PATCHARATRAKUL T, LINLAWAN S, PLAIDUM S, et al. The effect of rice vs. wheat ingestion on postprandial gastroesophageal reflux (GER) symptoms in patients with overlapping gerd-irritable bowel syndrome (IBS)[J]. Foods(Basel, Switzerland), 2021, 11(1): 26. DOI: 10.3390/foods11010026.
    [19]
    FAKHRE YASERI H. Gender is a risk factor in patients with gastroesophageal reflux disease[J]. Med J Islam Repub Iran, 2017, 31: 58. DOI: 10.14196/mjiri.31.58.
    [20]
    DE BORTOLI N, TOLONE S, FRAZZONI M, et al. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders[J]. Ann Gastroenterol, 2018, 31(6): 639-648.
    [21]
    SHINOZAKI S, OSAWA H, HAYASHI Y, et al. Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease[J]. Biomed Rep, 2021, 14(3): 32. DOI: 10.3892/br.2021.1408.
    [22]
    梁东飞, 贾子亮, 刘红国, 等. 胃食管反流病患者的流行病学分析[J]. 河北医药, 2023, 45(12): 1889-1891, 1897.

    LIANG D F, JIA Z L, LIU H G, et al. Epidemiological analysis of patients with gastroesophageal reflux disease[J]. Hebei Medicine, 2023, 45(12): 1889-1891, 1897.
    [23]
    ZHOU J, SHRESTHA P, QIU Z, et al. Distinct microbiota dysbiosis in patients with non-erosive reflux disease and esophageal adenocarcinoma[J]. J Clin Med, 2020, 9(7): 2162. DOI: 10.3390/jcm9072162.
    [24]
    BROERS C, GEERAERTS A, BOECXSTAENS V, et al. The role of serotonin in the control of esophageal sensitivity assessed by multimodal stimulation in health[J]. Neurogastroenterol Motil, 2021, 33(3): e14057. DOI: 10.1111/nmo.14057.
    [25]
    杨竹青, 郭敏, 王晓鸽, 等. 基于"上焦得通, 津液得下, 胃气因和"探讨胃食管反流病机制[J]. 北京中医药大学学报, 2023, 46(5): 711-716.

    YANG Z Q, GUO M, WANG X G, et al. Exploring the mechanism of gastroesophageal reflux disease based on "the upper jiao is cleared, the fluid is brought down, and the stomach qi is harmonized"[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023, 46(5): 711-716.
    [26]
    沈晓伶, 宋毓飞, 叶桦, 等. 肠易激综合征患者睡眠功能障碍分析及其与精神和胃肠道症状的相关性[J]. 中华全科医学, 2018, 16(4): 526-528. doi: 10.16766/j.cnki.issn.1674-4152.000145

    SHEN X L, SONG Y F, YE H, et al. Analysis of sleep dysfunction in patients with irritable bowel syndrome and its correlation with mental and gastrointestinal symptoms[J]. Zhonghua General Medicine, 2018, 16(4): 526-528. doi: 10.16766/j.cnki.issn.1674-4152.000145
    [27]
    PIMENTEL M. Evidence-based management of irritable bowel syndrome with diarrhea[J]. Am J Manag Care, 2018, 24(3 Suppl): S35-S46.
    [28]
    IGNOT-GUTIÉRREZ A, SERENA-ROMERO G, GUAJARDO-FLORES D, et al. Proteins and peptides from food sources with effect on satiety and their role as anti-obesity agents: a narrative review[J]. Nutrients, 2024, 16(20): 3560. DOI: 10.3390/nu16203560.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(3)

    Article Metrics

    Article views (5) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return